Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.290
+0.040 (1.78%)
At close: Nov 26, 2025, 4:00 PM EST
2.286
-0.004 (-0.16%)
After-hours: Nov 26, 2025, 7:06 PM EST
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $382.63 million as of November 26, 2025. Its market cap has decreased by -82.47% in one year.
Market Cap
382.63M
Enterprise Value
231.20M
1-Year Change
-82.47%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $382.63M, a decrease of -85.19%. That is a compound annual growth rate of -58.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 382.63M | -77.66% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 989.87B |
| Johnson & Johnson | 498.94B |
| AbbVie | 401.92B |
| UnitedHealth Group | 299.02B |
| AstraZeneca | 288.24B |
| Merck & Co. | 261.28B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.86B |